XML 23 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 4 - Intangible Assets, Net
12 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]
Note
4
. Intangible Assets, net
 
Intangible assets consist of trade names, license fees
from the Branded Proprietary Products Segment, and unpatented technology from the Other Nutraceutical Businesses Segment. The carrying amount of other intangible assets, net is as follows as of:
 
 
June 30, 2016
 
June 30, 2015
 
Gross Carrying
 
Accumulated
     
Gross Carrying
 
Accumulated
   
 
Amount
 
Amortization
 
Net
 
Amount
 
Amortization
 
Net
                       
Trade names and patents
$ 1,525
 
$ 1,290
 
$    235
 
$ 1,525
 
$    891
 
$  634
Unpatented technology
                     547
 
                  547
 
                  -
 
                     547
 
                  540
 
                    7
License agreement
      347
 
      347
 
          -
 
       347
 
      245
 
     102
Total
$ 2,419
 
$ 2,184
 
$    235
 
$ 2,419
 
$ 1,676
 
$  743
 
 
Amortization expense
and impairment charges recorded on intangible assets in the fiscal years ended June 30, 2016 and 2015 were $104 and $137 and $404 and none, respectively. Amortization expense is recorded on the straight-line method over periods ranging from 13 years to 15 years based on contractual or estimated lives (lowered from 20 years in the fiscal year ended June 30, 2016 impairment test) and is included in selling and administrative expenses. Tests for impairment or recoverability are performed at least annually and require significant management judgment and the use of estimates which the Company believes are reasonable and appropriate at the time of the impairment test. Future unanticipated events affecting cash flows and changes in market conditions could affect such estimates and result in the need for an impairment charge. The Company also re-evaluates the periods of amortization to determine whether circumstances warrant revised estimates of current useful lives. In the fiscal year ended June 30, 2016, an impairment loss of $0.4 million was identified and recorded resulting primarily from a change in the estimated useful lifes of the license agreement and the trade names and patents.  No impairment charges were identified or recorded in the fiscal year ended June 30, 2015 on the Company’s intangible assets.
 
The estimated annual amortization expense for intangible assets for the three succeeding fiscal years is as follows:
     
Year ending
 
Amortization
June 30,
 
Expense
2017
 
$ 101
2018
 
           101
2019
 
             33
Total
 
$ 235